Sicart Associates »

Cg Oncology shares owned by Sicart Associates

Quarter-by-quarter ownership of Cg Oncology shares owned by Sicart Associates from 13F filings

Historical chart of Sicart Associates investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Sicart Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Sicart Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 25k 43.90

More positions owned by Sicart Associates

Spdr Gold Tr Gold Shs (GLD)
Meta Platforms Cl A (META)
Netflix (NFLX)
Kraft Heinz (KHC)
FedEx Corporation (FDX)
Airbnb Com Cl A (ABNB)
SYSCO Corporation (SYY)
Alphabet Cap Stk Cl A (GOOGL)
Bunge Global Sa Com Shs (BG)
Albemarle Corporation (ALB)
Ionis Pharmaceuticals (IONS)
Gilead Sciences (GILD)
Intel Corporation (INTC)
Schlumberger Com Stk (SLB)
Walt Disney Company (DIS)

View all positions for Sicart Associates

Top funds holding Cg Oncology

BlackRock
Vanguard Group
BVF
Henderson Group
Avidity Partners Management
RA Capital Management
Perceptive Advisors
Braidwell
T. Rowe Price Associates
Franklin Resources
Cormorant Asset Management
Frazier Life Sciences Management
Holocene Advisors
T. Rowe Price Investment Management
Foresite Capital Management V

View all funds holding Cg Oncology